Aytu Biopharma Inc (AYTU)

May 04, 2025

Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Price Is Right But Growth Is Lacking After Shares Rocket 27% - simplywall.st

May 04, 2025

May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025

Apr 25, 2025

Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market - ACCESS Newswire

Apr 25, 2025

Apr 23, 2025

Aytu BioPharma at Planet MicroCap: Strategic Realignment and Growth By Investing.com - Investing.com Canada

Apr 23, 2025

Apr 22, 2025

Aytu BioPharma Stock Price, Quotes and Forecasts - Benzinga

Apr 22, 2025

Apr 22, 2025

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 | AYTU Stock News - GuruFocus

Apr 22, 2025

Apr 21, 2025

Aytu BioPharma CEO Reveals Growth Strategy at Exclusive Vegas Investor Showcase - Stock Titan

Apr 21, 2025

Apr 08, 2025

Aytu BioPharma, Inc. (NASDAQ:AYTU) On The Verge Of Breaking Even - simplywall.st

Apr 08, 2025

Apr 06, 2025

Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director - ACCESS Newswire

Apr 06, 2025

Apr 03, 2025

AYTU stock touches 52-week low at $1.13 amid market challenges - Investing.com India

Apr 03, 2025

Mar 27, 2025

Vascular Ehlers-Danlos Syndrome Market Growth Projections - openPR.com

Mar 27, 2025

Mar 26, 2025

Aytu BioPharma Strengthens Leadership Team with Appointment of Richard Eisenstadt as Chief Financial Officer - ACCESS Newswire

Mar 26, 2025

Mar 19, 2025

AYTU stock touches 52-week low at $1.2 amid market challenges - Investing.com Australia

Mar 19, 2025

Mar 16, 2025

AYTU BIOSCIENCE, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

Mar 16, 2025

Mar 08, 2025

AYTU stock touches 52-week low at $1.23 amid market challenges - Investing.com Australia

Mar 08, 2025

Mar 03, 2025

Insider Buying: Joshua Disbrow Acquires 15,000 Shares of Aytu Bi - GuruFocus.com

Mar 03, 2025

Mar 03, 2025

Aytu Biopharma CEO Joshua Disbrow buys $19,500 in stock - Investing.com India

Mar 03, 2025

Mar 03, 2025

Aytu Biopharma CEO Joshua Disbrow buys $19,500 in stock By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

AYTU BIOPHARMA CEO Acquires 15,000 Shares - TradingView

Mar 03, 2025

Feb 28, 2025

Aytu BioPharma Reports Second Quarter of Fiscal Year 2023 - ACCESS Newswire

Feb 28, 2025

Feb 27, 2025

Aytu BioPharma Regains Nasdaq Minimum Bid Price Compliance - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Aytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 Revenue - ACCESS Newswire

Feb 27, 2025

Feb 25, 2025

Earnings call transcript: Aytu BioPharma Q2 2025 sees revenue dip, strategic shifts - MSN

Feb 25, 2025

Feb 24, 2025

AYTU stock touches 52-week low at $1.3 amid market challenges - Investing.com Australia

Feb 24, 2025

Feb 24, 2025

AYTU stock touches 52-week low at $1.3 amid market challenges By Investing.com - Investing.com South Africa

Feb 24, 2025

Feb 24, 2025

Can This New Board Member Transform Evoke Pharma's Commercial Success? - StockTitan

Feb 24, 2025

Feb 21, 2025

Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021 - ACCESS Newswire

Feb 21, 2025

Feb 21, 2025

Aytu BioPharma anticipates positive cash flow with ADHD growth and $2M annual cost savings - MSN

Feb 21, 2025

Feb 17, 2025

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Second Year in a Row - ACCESS Newswire

Feb 17, 2025

Feb 15, 2025

Aytu BioPharma’s Imminent Breakthrough: Can It Reach Profitability? - Mi Valle

Feb 15, 2025

Feb 15, 2025

Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Set To Breakeven - Yahoo Finance

Feb 15, 2025

Feb 14, 2025

Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Stro - GuruFocus.com

Feb 14, 2025

Feb 13, 2025

Aytu BioScience Earnings Call: Growth Amid Challenges - TipRanks

Feb 13, 2025

Feb 13, 2025

Denver biotech cuts $500K check when it parted ways with its CFO - The Business Journals

Feb 13, 2025

Feb 13, 2025

Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Strong Cash Position and Strategic ... By GuruFocus - Investing.com Canada

Feb 13, 2025

Feb 13, 2025

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2025 Earnings Call Transcript - Insider Monkey

Feb 13, 2025

Feb 12, 2025

Aytu BioPharma Reports Strong Q2 Earnings Growth - TipRanks

Feb 12, 2025

Feb 12, 2025

Aytu BioPharma Inc. (AYTU) reports earnings - Quartz

Feb 12, 2025

Feb 12, 2025

AYTU BIOPHARMA, INC SEC 10-Q Report - TradingView

Feb 12, 2025

Feb 12, 2025

Aytu BioPharma Reports Fiscal 2025 Second Quarter Results - TradingView

Feb 12, 2025

Feb 12, 2025

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results - ACCESS Newswire

Feb 12, 2025

Feb 12, 2025

Aytu BioPharma Turns Profitable: Key Portfolio Growth Drives Q2 Transformation - StockTitan

Feb 12, 2025

Feb 06, 2025

Aytu BioPharma Reports First Quarter 2022 Financial Results - ACCESS Newswire

Feb 06, 2025

Feb 05, 2025

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025 - Galveston County Daily News

Feb 05, 2025